The relentless march of time is an inescapable fact, but its effects on our overall well-being are profound and intricate. Referred to by some experts as the “master disease”, aging is more than merely growing older. It represents the functional decline of a living organism over time. This article probes into the multifaceted nature of biological aging, its repercussions, and the innovative ways in which science is demystifying and even countering its challenges. [Read more…]
Ajinomoto Co. to Acquire Gene Therapy CDMO Forge Biologics for an Astounding $620 Million
- Acquisition extends global capabilities in AAV and plasmid gene therapy manufacturing for Ajinomoto, Co. Inc., diversifying and strengthening their current contract development and manufacturing services
- Positions Forge Biologics for accelerated long-term growth supporting gene and cell therapy clients worldwide
Atsena Therapeutics Receives FDA RMAT Designation for ATSN-101 Gene Therapy
RMAT designation recognizes the potential of ATSN-101 to address unmet medical needs for patients with LCA1
ATSN-101 has demonstrated clinically meaningful improvements in vision at the highest dose with no drug-related serious adverse events 6 months post-treatment in ongoing Phase I/II clinical trial
iPSC Market Leaders and their Business Models
Today, induced pluripotent stem cells (iPSCs) are being exploited for uses in drug discovery and development, toxicology screening, disease modelling, personalized medicine, cell-based therapeutics, and beyond. A fascinatingly diverse range of business models have been developed by market competitors to provide iPSC specific products, services, technologies, and therapies across the life science sector. [Read more…]
Avid Bioservices Completes Construction of World-Class Cell and Gene Therapy Development & Manufacturing Facility
Newly Launched CGMP Manufacturing Suites Undergoing Final Environmental Monitoring and Performance Qualification with Grand Opening Planned for January 2024
Completion of CGT Facility Brings Company’s Total Revenue Generating Capacity to up to Approximately $400 Million Annually
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 47
- Next Page »